Helga Mikkelsen

Helga Mikkelsen

Private Equity Investor chez
Brandon Capital Partners Pty Ltd.
Consumer Services
Finance
Health Technology

Profil

Helga joined Brandon Capital in 2018.
Before joining Helga was part of the team that developed a novel treatment for respiratory disease at the Telethon Kids Institute in Perth, which subsequently became Respirion Pharmaceuticals.
Previously Helga project managed the development of anti-infective medical devices for CamStent in Cambridge, UK.
Helga undertook postdoctoral training in bacterial genetics at Imperial College London.
Helga is a board observer of OncoRes Medical and Respirion Pharmaceuticals.
Helga has both a Bachelor and Masters of Science in Chemical Engineering and Biotechnology from the Technical University of Denmark and a PhD in Microbiology from the University of Cambridge.
She is a Graduate of the Australian Institute of Company Directors.

Postes actifs de Helga Mikkelsen

SociétésPosteDébut
Private Equity Investor 31/12/2022

Anciens postes connus de Helga Mikkelsen

SociétésPosteFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Helga Mikkelsen

Formation de Helga Mikkelsen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

8

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Consumer Services

Consumer Services

Consumer Services

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Helga Mikkelsen
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇